Eliem Therapeutics Correlations
| ELYMDelisted Stock | USD 3.00 0.08 2.60% |
The current 90-days correlation between Eliem Therapeutics and Rezolute is 0.05 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eliem Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eliem Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Eliem Therapeutics Correlation With Market
Significant diversification
The correlation between Eliem Therapeutics and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Eliem |
Moving together with Eliem Stock
| 0.71 | EC | Ecopetrol SA ADR | PairCorr |
| 0.8 | HYMTF | Hyundai Motor | PairCorr |
| 0.85 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.89 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.71 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
| 0.8 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
Moving against Eliem Stock
| 0.87 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.86 | CSCO | Cisco Systems | PairCorr |
| 0.85 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.8 | HPQ | HP Inc | PairCorr |
| 0.76 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.75 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
| 0.75 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.72 | WMT | Walmart Aggressive Push | PairCorr |
| 0.71 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.67 | XOM | Exxon Mobil Corp Aggressive Push | PairCorr |
| 0.6 | KB | KB Financial Group | PairCorr |
| 0.58 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.32 | VFS | VinFast Auto Earnings Call This Week | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Eliem Stock performing well and Eliem Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Eliem Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| PMVP | 1.67 | (0.03) | (0.02) | 0.06 | 2.12 | 3.75 | 13.98 | |||
| MNOV | 5.00 | 1.29 | 0.18 | (0.44) | 4.13 | 14.50 | 61.30 | |||
| PHVS | 2.88 | 0.21 | 0.07 | 0.28 | 2.98 | 7.76 | 21.41 | |||
| PEPG | 3.02 | (1.30) | 0.00 | (0.73) | 0.00 | 4.75 | 26.81 | |||
| ANEB | 5.22 | (0.27) | 0.00 | (0.04) | 0.00 | 8.85 | 76.00 | |||
| RZLT | 2.90 | 0.09 | 0.04 | 0.16 | 3.10 | 6.81 | 30.01 | |||
| HCWB | 13.16 | 4.23 | 0.41 | (1.40) | 7.33 | 22.00 | 341.22 | |||
| MOLN | 4.73 | (0.11) | (0.02) | 0.00 | 5.15 | 9.61 | 52.92 | |||
| AVTE | 2.56 | 0.45 | 0.17 | 0.54 | 2.14 | 5.58 | 19.11 | |||
| ADAG | 4.50 | (0.02) | (0.01) | 0.06 | 6.87 | 8.30 | 37.93 |
| The entity Eliem Therapeutics with a symbol ELYM was recently relisted or delisted. You can potentially use Climb Bio with a symbol CLYM. Please make sure the ticker renaming or change in the classification of Eliem Therapeutics is not a temporary action by the exchange. |
Eliem Therapeutics Corporate Management
| Erin Lavelle | COO VP | Profile | |
| MD MBA | Chief Officer | Profile | |
| James JD | Gen VP | Profile | |
| Jo PalmerPhillips | Chief Officer | Profile | |
| Valerie Morisset | Chief Development | Profile | |
| Emily Pimblett | Principal Officer | Profile |
Still Interested in Eliem Therapeutics?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.